GobyMeds vs Willow: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent research·How we rank →

GobyMeds beats Willow overall, scoring 8.4/10 vs 8.2/10. GobyMeds is more affordable at $169/mo vs $299/mo. Choose GobyMeds for budget-conscious users who want a modern, well-reviewed comp. Choose Willow for users who want comprehensive clinical support with flexibili.

A side-by-side comparison of GobyMeds and Willow covering pricing, scores, medication types, insurance, and more to help you decide.

Higher Rated

GobyMeds

#5 of 48

8.4/10

Fast-growing compounded GLP-1 provider with strong Reddit reviews, competitive pricing, and a clean user experience that punches above its price point.

Visit GobyMeds

Willow

#8 of 48

8.2/10

Personalized GLP-1 weight loss with ongoing clinical support. Compounded semaglutide and tirzepatide only — Willow explicitly does not prescribe brand-name Wegovy or Zepbound. Added oral compounded semaglutide tablets as a non-injectable option.

Visit Willow

Feature	GobyMeds	Willow
Our Score	8.4/10	8.2/10
Starting Price	$169/mo	$299/mo
Medication Type	Both	Compounded
Insurance Accepted	No	No
Best For	Budget-conscious users who want a modern, well-reviewed compounded GLP-1 program	Users who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes
Ranking	#5	#8

Pros & Cons Compared

GobyMeds

Pros

+$119/mo starting price is among the most affordable for a full-service compounded program
+Consistently positive Reddit reviews citing fast shipping, responsive support, and clean UX
+Modern patient portal with real-time order tracking and easy provider messaging
+Quick onboarding — most patients approved and shipped within 48 hours of enrollment

Cons

−Compounded semaglutide only — no tirzepatide, no brand-name, no oral options
−Newer company with less track record than established players like Ro or Hims
−No insurance billing and no superbills for FSA/HSA reimbursement

Willow

Pros

+Includes monthly provider check-ins and dose adjustments at no extra cost
+Offers both injectable AND oral compounded semaglutide — one of few platforms with a daily oral tablet option
+$299/mo all-in for compounded semaglutide with monthly provider support
+90%+ patient retention rate after 3 months per their published outcomes data

Cons

−Compounded-only — no brand-name Wegovy or Zepbound through the platform
−Tirzepatide pricing reaches $499-$524 at higher doses — starting dose is $399/mo
−Cash-pay only — no insurance billing, though they provide superbills for FSA/HSA
−Founded in 2024 — less track record than Ro or Hims, though growth has been fast

Our Verdict

GobyMeds edges out Willow with a score of 8.4/10 vs 8.2/10. If budget is your priority, GobyMeds starts at $169/mo compared to Willow's $299/mo. GobyMeds offers both brand-name and compounded medications, giving you more flexibility. Choose GobyMeds if you want: budget-conscious users who want a modern, well-reviewed compounded glp-1 program. Choose Willow if you want: users who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes.

Still undecided? Editor's #1 Overall Pick

Embody

$299/mo · 7.3/10 · Compounded

If neither GobyMeds nor Willow feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Embody — strongest balance of clinical oversight, transparent pricing, and verified availability.

Visit Embody→Read our full Embody review